No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kiromic BioPharma | 10-K: Annual report
Kiromic Files to Raise $17M Through Uplisting
Kiromic Biopharma, Now on OTCQB, Files to Offer Units Consisting of Stock and Warrants and Seeks NYSE American Listing
Express News | Kiromic Biopharma Inc -Applied to List Common Stock on the NYSE American Under Symbol “Krbp”
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Financial Crime Weekly: CEO Sentenced To 51 Months In Prison, Kiromic BioPharma Charged With Failure To Disclose Material Information